LITAZONE 30 pioglitazone (as hydrochloride) 30mg tablet blister pack

Active ingredient:

pioglitazone hydrochloride, Quantity: 33.072 mg (Equivalent: pioglitazone, Qty 30 mg)

Available from:

Medis Pharma Pty Ltd

INN (International Name):

Pioglitazone hydrochloride

Pharmaceutical form:

Tablet

Composition:

Excipient Ingredients: lactose monohydrate; carmellose calcium; hyprolose; magnesium stearate

Administration route:

Oral

Units in package:

7 tablets, 28 tablets, 50 tablets, 98 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Treatment of type 2 diabetes inadequately controlled by diet and exercise: ? As monotherapy ? As dual therapy to improve glycaemic control - In combination with metformin or sulfonylurea - In combination with insulin ? As triple therapy to improve glycaemic control - In combination with metformin and sulfonylurea

Product summary:

Visual Identification: White to off white, round, flat faced beveled edge uncoated tablets debossed with break-line separating '11' and '19' on one side and break-line on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/PE; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Registered

Authorization date:

2011-10-26